PE
2000
$4 500 M
Sydney, New South Wales, Australia
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Crescent Capital Partners (Crescent) is one of the oldest and most successful Australian-based private equity and alternative asset firms. Founded in 2000, Crescent began as a private equity firm focused on mid-market ‘growth buy-out’ transactions and is today an alternative asset manager continuing to cover Australian and New Zealand private equity but also offering private credit and active listed equities fund products.
As a private equity manager, Crescent is a top quartile global fund manager (as measured by Cambridge Associates benchmarks) with a strong track record in delivering superior returns to investors that is the hallmark of its success to date. Crescent has closed multiple funds since its inception with total capital raised in excess of A$4.5 billion.
Crescent is well known for its deep experience and skill set in investing into healthcare, industrial, financial and services businesses, and we use this expertise and deep sector knowledge to inform investment decisions. In particular, Crescent has been the most active private equity manager in healthcare transactions in Australia measured by number of investments made over the past 10 years.
Crescent is offering wholesale investors access to its various funds through direct investment and via recognised wealth platforms.
Industry
Region of investment
Crescent Capital Partners Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Crescent Capital Partners Fund VI
|
Private Equity (PE)
|
Food and Beverage
Foodtech
Healthcare Services
Energy
HealthTech
|
Series B
Late Stage (Series C+)
|
Australia and others
|
$5-10 m
|
$529 M
|
August 2018
|
|
Crescent Capital Partners Fund VII
|
Private Equity (PE)
|
Healthcare Services
Energy
HealthTech
|
Series B
Late Stage (Series C+)
|
Australia and others
|
$5-10 m
|
$670 M
|
April 2023
|